Fresenius | FRE - Loan Capital



Fresenius reported EUR9.31B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Akzo Nobel EUR 3.66B 514M Jun/2025
Alcon AG USD 4.66B 68M Jun/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
BASF EUR 18.96B 85M Jun/2025
Bayer EUR 31.71B 3.31B Jun/2025
Beiersdorf EUR 132M 20M Jun/2025
DaVita Healthcare Partners USD 10.08B 519.06M Jun/2025
Demant DKK 15.27B 677M Jun/2025
E.ON EUR 34.72B 753M Jun/2025
Essilor EUR 9.37B 431M Jun/2025
Fresenius EUR 9.31B 2.08B Jun/2025
Fresenius Medical Care EUR 6.33B 3.18B Jun/2025
Getinge SEK 8.28B 1.08B Dec/2024
Givaudan CHF 4.29B 175M Jun/2024
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
GN Store Nord DKK 9.04B 279M Jun/2025
GRIFOLS EUR 7.45B 1.94B Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 6.3B 665M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Philips EUR 7.18B 126M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
RWE EUR 15.08B 813M Jun/2025
Sanofi 13.2B 211M Jun/2025
Smith & Nephew USD 3.3B 39M Jun/2025